Retraction
Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial
Paper Information
Record ID:
32487
Author(s):
Journal:
Publication Date:
March 21, 2021
Retraction Date:
September 18, 2021
(4.2 years years ago)
Subjects:
Broad Categories:
Medicine
Medicine
Institutions:
- Tropical Medicine Department, Faculty of Medicine, Ain Shams University, Ramsis Street, Abbassia Square, Cairo, 11591, Egypt
- Faculty of Medicine, Ain Shams University Research Institute-Clinical Research Centre (MASRI-CRC), Cairo, Egypt
- Chest Department, Ain Shams University, Cairo, Egypt
- Community Medicine Department, Ain Shams University, Cairo, Egypt
- Tropical Medicine Department, Assiut University, Assiut, Egypt
Country:
🇪🇬 EgyptArticle Type:
Publisher:
Springer - Nature Publishing Group
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (48)
48
Total Citations33
Post-Retraction(68.8%)
15
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
4
Within 30 days
19
Within 1 year
6
After 2+ years
1321
Days since retraction (latest)
Efficacy and safety of remdesivir and favipiravir in COVID-19 patients – A systematic review and meta-analysis
Piyush Vatsha, Gyan Vardhan, Tanushree Kumari et al. (6 authors)
Journal of Family Medicine and Primary Care
Open Access
Published: May 2025
1321 days after retraction
Concerns about data integrity of randomized clinical trials from one author in the European Journal of Gastroenterology & Hepatology
Kelly X. Zhou, Gideon Meyerowitz‐Katz, Tim Skern et al. (4 authors)
European Journal of Gastroenterology & Hepatology
Published: Mar 2025
1285 days after retraction
SARS-CoV 2 Viral Clearance in 1276 Patients: Associated Factors and the Role of Treatment with Hydroxychloroquine and Azithromycin
P. Brouqui, Didier Raoult
ACTA SCIENTIFIC MICROBIOLOGY
Open Access
Published: Aug 2024
1048 days after retraction
Clinical Course and Factors Associated With Hospital Admission and Mortality among Sars-Cov 2 Patients within Nairobi Metropolitan Area.
Augustine Gatimu Njuguna, A Wangombe, Michael Walekhwa et al. (4 authors)
medRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: May 2024
970 days after retraction
Hospitalization Endpoint in Clinical Trials of Outpatient Settings: using Anti-SARS-COV-2 Therapy as an Example
Alhanouf Alnafisah, Ahmed Alkhalidi, Hanin Aljohani et al. (6 authors)
Clinical Epidemiology
Open Access
Published: May 2024
1 citation
1 citation
956 days after retraction
Multi-epitopes vaccine design for surface glycoprotein against SARS-CoV-2 using immunoinformatic approach
Sarmad Frogh Arshad, Rehana Rehana, Muhammad Asif Saleem et al. (11 authors)
Heliyon
Open Access
Published: Jan 2024
7 citations
7 citations
835 days after retraction
Retraction of Clinical Trials about the SARS-CoV-2 Infection: An Unaddressed Problem and Its Possible Impact on Coronavirus Disease (COVID)-19 Treatment
Felipe Eduardo Valencise, Camila Vantini Capasso Palamim, Fernando Augusto Lima Marson
International Journal of Environmental Research and Public Health
Open Access
Published: Jan 2023
8 citations
8 citations
488 days after retraction
Pyridine Derivatives as Potential Inhibitors for Coronavirus SARS-CoV-2: A Molecular Docking Study
Kamaraj Karthick, Kalaiyar Swarnalatha
Bioinformatics and Biology Insights
Open Access
Published: Jan 2023
2 citations
2 citations
470 days after retraction
Small molecules in the treatment of COVID-19
Sibei Lei, Xiaohua Chen, Jieping Wu et al. (5 authors)
Signal Transduction and Targeted Therapy
Open Access
Published: Dec 2022
88 citations
88 citations
443 days after retraction
Biased, wrong and counterfeited evidences published during the COVID-19 pandemic, a systematic review of retracted COVID-19 papers
Angelo Capodici, Aurelia Salussolia, Francesco Sanmarchi et al. (5 authors)
Quality & Quantity
Open Access
Published: Nov 2022
13 citations
13 citations
437 days after retraction
Favipiravir: An Antiviral Drug
Ganesh Bharskar, Pratik V. Malvade
Research Journal of Pharmaceutical Dosage Forms and Technology
Published: Nov 2022
3 citations
3 citations
422 days after retraction
A Comprehensive Review on the Efficacy of Several Pharmacologic Agents for the Treatment of COVID-19
Fatma Haddad, Ghadeer Dokmak, Rafik Karaman
Life
Open Access
Published: Nov 2022
22 citations
22 citations
409 days after retraction
EVALUATION OF OSELTAMIVIR AND FAVIPIRAVIR ON CLINICAL OUTCOMES AND LENGTH OF STAY IN COVID-19 PATIENTS AT FATMAWATI GENERAL HOSPITAL JAKARTA
Mareoza Ayutri, Retnosari Andrajati, Ahmad Subhan
Asian Journal of Pharmaceutical and Clinical Research
Open Access
Published: Oct 2022
384 days after retraction
Consistency of covid-19 trial preprints with published reports and impact for decision making: retrospective review
Dena Zeraatkar, Tyler Pitre, Gareth Leung et al. (19 authors)
BMJ Medicine
Open Access
Published: Oct 2022
36 citations
36 citations
378 days after retraction
Perspective: repurposed Drugs for COVID-19
Kesara Na‐Bangchang, Supattra Porasuphatana, Juntra Karbwang
Archives of Medical Science
Open Access
Published: Aug 2022
7 citations
7 citations
346 days after retraction
Safety of Short-Term Treatments with Oral Chloroquine and Hydroxychloroquine in Patients with and without COVID-19: A Systematic Review
Sergio Marín, Alba Martin Val, Maite Bosch Peligero et al. (9 authors)
Pharmaceuticals
Open Access
Published: May 2022
13 citations
13 citations
245 days after retraction
Favipiravir for treating COVID-19
Pritish John Korula, Hanna Alexander, Jisha Sara John et al. (7 authors)
Cochrane library
Open Access
Published: May 2022
1 citation
1 citation
229 days after retraction
Efficacy and Outcome of Remdesivir and Tocilizumab Combination Against Dexamethasone for the Treatment of Severe COVID-19: A Randomized Controlled Trial
Abu Taiub Mohammed Mohiuddin Chowdhury, Aktar Kamal, Kafil Uddin Abbas et al. (9 authors)
Frontiers in Pharmacology
Open Access
Published: Apr 2022
19 citations
19 citations
199 days after retraction
A validated UHPLC-MS/MS method for simultaneous quantification of some repurposed COVID-19 drugs in rat plasma: Application to a pharmacokinetic study
Noha F. El Azab
Microchemical Journal
Open Access
Published: Mar 2022
19 citations
19 citations
166 days after retraction
AYUSH-64 as an adjunct to standard care in mild to moderate COVID-19: An open-label randomized controlled trial in Chandigarh, India
Harbans Singh, Sumit Srivastava, Babita Yadav et al. (15 authors)
Complementary Therapies in Medicine
Open Access
Published: Feb 2022
25 citations
25 citations
143 days after retraction
Addendum: The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials
Soheil Hassanipour, Morteza Arab‐Zozani, Bahman Amani et al. (6 authors)
Scientific Reports
Open Access
Published: Feb 2022
6 citations
6 citations
136 days after retraction
Efficacy of antiviral therapies for COVID-19: a systematic review of randomized controlled trials
Charan Thej Reddy Vegivinti, Kirk W. Evanson, Hannah Lyons et al. (22 authors)
BMC Infectious Diseases
Open Access
Published: Jan 2022
101 citations
101 citations
135 days after retraction
Treatment adherence of COVID-19 patients getting medication at home
Ahmet Önder PORSUK, Cerit Cigdem
SANAMED
Open Access
Published: Jan 2022
105 days after retraction
Enhancing the Antiviral Potency of Nucleobases for Potential Broad-Spectrum Antiviral Therapies
Rubén Soto-Acosta, Tiffany C. Edwards, Christine D. Dreis et al. (9 authors)
Viruses
Open Access
Published: Dec 2021
4 citations
4 citations
87 days after retraction
Pharmacological treatment of COVID-19: an opinion paper
Alberto García‐Lledó, Javier Gómez‐Pavón, Juan González del Castillo et al. (15 authors)
Revista Española de Quimioterapia
Open Access
Published: Dec 2021
62 citations
62 citations
84 days after retraction
The therapeutic efficacy of quercetin in combination with antiviral drugs in hospitalized COVID-19 patients: A randomized controlled trial
Mojtaba Shohan, Roohangiz Nashibi, Mohammad‐Reza Mahmoudian‐Sani et al. (8 authors)
European Journal of Pharmacology
Open Access
Published: Dec 2021
90 citations
90 citations
75 days after retraction
Evaluation of favipiravir in the treatment of COVID-19 based on the real-world
Weishang Deng, Changyuan Yang, Sensen Yang et al. (6 authors)
Expert Review of Anti-infective Therapy
Open Access
Published: Nov 2021
17 citations
17 citations
73 days after retraction
Effectiveness of Remdesivir, Lopinavir/Ritonavir, and Favipiravir for COVID-19 Treatment: A Systematic Review
Windi Fresha Qomara, Delya Nur Primanissa, Salma Hasni Amalia et al. (5 authors)
International Journal of General Medicine
Open Access
Published: Nov 2021
54 citations
54 citations
44 days after retraction
Safety of Chloroquine or Hydroxychloroquine Plus Azithromycin for the Treatment of COVID-19 Patients in Burkina Faso: An Observational Prospective Cohort Study
Toussaint Rouamba, Houreratou Barry, Espérance Ouédraogo et al. (20 authors)
Therapeutics and Clinical Risk Management
Open Access
Published: Nov 2021
10 citations
10 citations
44 days after retraction
2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19
Alessia Alunno, Aurélie Najm, Pedro Machado et al. (24 authors)
Annals of the Rheumatic Diseases
Open Access
Published: Oct 2021
37 citations
37 citations
19 days after retraction
The quest for a better fight: How can nanomaterials address the current therapeutic and diagnostic obstacles in the fight against COVID-19?
Sheyda Ranjbar, Yousef Fatahi, Fatemeh Atyabi
Journal of Drug Delivery Science and Technology
Open Access
Published: Oct 2021
6 citations
6 citations
16 days after retraction
Immunomodulatory therapies for the treatment of SARS-CoV-2 infection: an update of the systematic literature review to inform EULAR points to consider
Alessia Alunno, Aurélie Najm, Xavier Mariette et al. (8 authors)
RMD Open
Open Access
Published: Oct 2021
11 citations
11 citations
13 days after retraction
Efficacy of COVID-19 Treatments: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
Chenyang Zhang, Huaqing Jin, Yi Feng Wen et al. (4 authors)
Frontiers in Public Health
Open Access
Published: Sep 2021
38 citations
38 citations
10 days after retraction
Clinical Efficacy and Safety of Antiviral Drugs in the Extended Use against COVID-19: What We Know So Far
Md. Jamal Hossain, Tabassum Jannat, Shejuti Rahman Brishty et al. (10 authors)
Biologics
Open Access
Published: Sep 2021
15 citations
15 citations
3 days before retraction
Interactions between favipiravir and a BNC cage towards drug delivery applications
Azar Asgari Pari, Mohammad Yousefi
Structural Chemistry
Open Access
Published: Sep 2021
8 citations
8 citations
10 days before retraction
Effectiveness and Safety of Favipiravir Compared to Hydroxychloroquine for Management of Covid-19: A Retrospective Study
Musim Alotaibi, Ahmed S. Ali, Duaa Bakhshwin et al. (11 authors)
International Journal of General Medicine
Open Access
Published: Sep 2021
13 citations
13 citations
17 days before retraction
Randomized Controlled Trials on COVID-19 Should Be Accurate and Trustworthy
Ben W. Mol
American Journal of Tropical Medicine and Hygiene
Open Access
Published: Aug 2021
1 citation
1 citation
19 days before retraction
Response to “Randomized Controlled Trials on COVID-19 Should be Accurate and Trustworthy”
Sherief Abd‐Elsalam, Shaimaa Soliman
American Journal of Tropical Medicine and Hygiene
Open Access
Published: Aug 2021
1 citation
1 citation
19 days before retraction
India and management of COVID-19: A case study on published guidelines
Rohit Kumar, Ankit Mittal, Shreya Das Adhikari et al. (5 authors)
Drug Discoveries & Therapeutics
Open Access
Published: Aug 2021
24 days before retraction
Favipiravir versus standard of care in patients with severe COVID-19 infections: A retrospective comparative study
Zainab Almoosa, Mustafa Saad, Samer Qara et al. (14 authors)
Journal of Infection and Public Health
Open Access
Published: Aug 2021
11 citations
11 citations
25 days before retraction
AYUSH-64 as an adjunct to Standard Care in mild to moderate COVID-19: An open-label randomized controlled trial in Chandigarh, India
Harbans Singh, Sumit Shrivastva, Babita Yadav et al. (15 authors)
Unknown Journal
Open Access
Published: Aug 2021
1 citation
1 citation
43 days before retraction
Effectiveness of favipiravir in COVID-19: a live systematic review
Batu Özlüşen, Şima Kozan, Rüştü Emre Akcan et al. (9 authors)
European Journal of Clinical Microbiology & Infectious Diseases
Open Access
Published: Aug 2021
70 citations
70 citations
45 days before retraction
Clinical Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP)
Matteo Bassetti, Daniele Roberto Giacobbe, Paolo Bruzzi et al. (56 authors)
Infectious Diseases and Therapy
Open Access
Published: Jul 2021
34 citations
34 citations
50 days before retraction
COVID-19 recovery measures and use of medications among COVID-19 patients at home: A cross- sectional study in Bangladesh
Abdullah Al Noman, Taufique Joarder, Md. Shofiqul Islam et al. (12 authors)
Research Square (Research Square)
Published: Jun 2021
2 citations
2 citations
103 days before retraction
Nanomedicine: A Diagnostic and Therapeutic Approach to COVID-19
Arjun Sharma, Konstantinos Kontodimas, Markus Bosmann
Frontiers in Medicine
Open Access
Published: Jun 2021
35 citations
35 citations
106 days before retraction
Perspectives on Antiviral Drugs Development in the Treatment of COVID-19
Aura Rusu, Eliza Mihaela Arbănași, Ioana-Andreea Lungu et al. (4 authors)
Acta Biologica Marisiensis
Open Access
Published: Jun 2021
2 citations
2 citations
109 days before retraction
The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials
Soheil Hassanipour, Morteza Arab‐Zozani, Bahman Amani et al. (6 authors)
Scientific Reports
Open Access
Published: May 2021
239 citations
239 citations
115 days before retraction
Understanding the clinical utility of favipiravir (T-705) in coronavirus disease of 2019: a review
Kritika Srinivasan Rajsri, Mana Rao
Therapeutic Advances in Infectious Disease
Open Access
Published: Jan 2021
14 citations
14 citations
260 days before retraction
Quick Stats
Total Citations:
48
Years Since Retraction:
4.2 years
Open Access:
Yes
Last Checked:
Jul 24, 2025